Choudhary Manoj, Bankole Ibukunoluwa A, McDuffee Sophia T, Parajuli Apekshya, Poudel Mousami, Balogh Botond, Paret Mathews L, Jones Jeffrey B
Indian Council of Agriculture Research, New Delhi 110001, India.
Department of Plant Pathology, University of Florida, Gainesville, FL 32611, USA.
Viruses. 2025 Jul 23;17(8):1033. doi: 10.3390/v17081033.
The rise in antibiotic-resistant bacteria has made the management of bacterial diseases increasingly challenging. As a result, bacteriophages have gained attention as a promising alternative to antibiotics for combating bacterial pathogens. However, the usage of phages as biocontrol agents faces many challenges, including environmental stability, delivery efficiency, host specificity, and potential bacterial resistance. Advancements in genetic engineering and nanotechnology have been explored to enhance the stability, efficacy, and adaptability of phage-based treatments. In this review, we discuss the key barriers to the effective implementation of phage therapy and highlight innovative strategies to overcome these challenges. By addressing these limitations, this review aims to provide insights into optimizing phage-based approaches for widespread therapeutic and biocontrol applications.
抗生素耐药细菌的增加使得细菌性疾病的管理面临越来越大的挑战。因此,噬菌体作为对抗细菌病原体的一种有前景的抗生素替代品而受到关注。然而,将噬菌体用作生物防治剂面临许多挑战,包括环境稳定性、递送效率、宿主特异性和潜在的细菌耐药性。人们已经探索了基因工程和纳米技术的进展,以提高基于噬菌体的治疗方法的稳定性、疗效和适应性。在这篇综述中,我们讨论了有效实施噬菌体疗法的关键障碍,并强调了克服这些挑战的创新策略。通过解决这些限制,本综述旨在为优化基于噬菌体的方法以实现广泛的治疗和生物防治应用提供见解。